This chapter covers the use of a membrane in a conventional hemodialysis process, where
the blood of the end-stage renal failure patient is purified. The operational similarity between …

Objective: Unusual or unexpected effect of treatment Background: Biocompatible
hemodialysis membranes have greatly advanced the treatment of renal failure. Synthetic …

Leukopenia or thrombocytopenia is sometimes observed in end-stage renal disease
(ESRD) patients, but the association between chronic leukopenia or thrombocytopenia and …

A well‐functioning vascular access is essential for provision of life‐sustaining dialysis
treatment in patients with end‐stage renal disease. Arteriovenous accesses are preferred …

We present a case of a 47-year-old man with severe thrombocytopenia. The differential
diagnosis for thrombocytopenia is wide. The assessment includes an evaluation for falsely …

The article discusses the treatment management case study on a transfusion-related
thrombocytopenia in a chronic renal failure African-American patient. Topics include the …

The traditional case report consists of a title, abstract, introduction, case description,
discussion, and conclusion with a teaching point. This chapter describes how to write a …

Kidney failure patients rely on haemodialysis treatment to survive. However, unlike the
kidney, this treatment cannot remove protein bound uremic toxins effectively and its long …

Abstract Background: Chronic Kidney Disease (CKD) is an emerging public health problem
worldwide. The increasing cost of healthcare, particularly in developing nations like India, is …

Hemostasis is a process to stop bleeding that requires coordinated activities of vascular,
platelet, and plasma factors. Under normal conditions, blood vessel injury will trigger …